Massachusetts Financial Services Co. MA Purchases 1,884 Shares of Teleflex Incorporated (NYSE:TFX)

Massachusetts Financial Services Co. MA grew its position in Teleflex Incorporated (NYSE:TFX) by 0.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 427,579 shares of the medical technology company’s stock after purchasing an additional 1,884 shares during the period. Massachusetts Financial Services Co. MA owned about 0.92% of Teleflex worth $105,749,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Cromwell Holdings LLC increased its stake in Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after buying an additional 49 shares during the last quarter. Avior Wealth Management LLC grew its holdings in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares in the last quarter. Ashton Thomas Securities LLC purchased a new stake in shares of Teleflex during the third quarter valued at approximately $40,000. Canada Pension Plan Investment Board bought a new stake in Teleflex during the second quarter worth $42,000. Finally, GAMMA Investing LLC boosted its position in Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after purchasing an additional 97 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

NYSE TFX opened at $191.71 on Friday. The firm has a market cap of $8.90 billion, a P/E ratio of 38.11, a price-to-earnings-growth ratio of 1.95 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company’s 50 day moving average is $224.99 and its 200-day moving average is $222.73. Teleflex Incorporated has a 12-month low of $185.66 and a 12-month high of $257.85.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the previous year, the firm posted $3.64 EPS. The business’s revenue for the quarter was up 2.4% compared to the same quarter last year. Sell-side analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be issued a dividend of $0.34 per share. The ex-dividend date is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial restated a “hold” rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Finally, Mizuho dropped their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $259.25.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.